# Adicet Bio

> Adicet Bio, Inc. (Nasdaq: ACET) is a clinical-stage biotechnology company developing
> allogeneic "off-the-shelf" gamma delta T cell therapies engineered with chimeric antigen
> receptors (CARs) for autoimmune disease and cancer.

generated: 2026-09-07
method: generated
source: apis.yml + www.adicetbio.com (probed 2026-09-07); the provider serves no /llms.txt

Adicet Bio has no public API, developer portal, SDK, CLI, MCP server, agent card, or any
other machine-readable interface. This file is an API Evangelist-generated summary of the
company's public web surface, not a provider-published document. Probes run 2026-09-07
against adicetbio.com, www.adicetbio.com and investor.adicetbio.com returned 404/301/403
for every OpenAPI, Swagger, GraphQL, llms.txt and /.well-known/ path attempted.

## Company

- [Adicet Bio](https://www.adicetbio.com/): Corporate home page — gamma delta T cell platform overview.
- [Science](https://www.adicetbio.com/science/): Gamma delta T cell biology, the allogeneic platform, and novel targeting moieties.
- [Pipeline](https://www.adicetbio.com/pipeline/): Clinical pipeline, including prulacabtagene leucel (prula-cel, anti-CD20 gamma delta CAR T) and ADI-212.
- [About](https://www.adicetbio.com/about/): Leadership, board of directors, and scientific advisory board.
- [Contact](https://www.adicetbio.com/contact/): Redwood City, CA and Boston, MA offices.

## Careers

- [Careers overview](https://www.adicetbio.com/careers/overview/)
- [Current openings](https://www.adicetbio.com/careers/openings/)

## Legal

- [Terms of Use](https://www.adicetbio.com/terms-of-use/)
- [Privacy Policy](https://www.adicetbio.com/privacy/)
- [Cookie Notice](https://www.adicetbio.com/cookie-notice/)

## Optional

- [Investor relations](https://investor.adicetbio.com/): Vendor-hosted IR portal (SEC filings, news releases, events). Returns HTTP 403 to non-browser clients.